Psilocybin mushrooms

Psilocybin mushrooms, commonly known as magic mushrooms, contain psilocybin, a psychoactive compound that can alter perception and mood, making them both subjects of recreational use and scientific investigation into potential therapeutic benefits.

Studies have found that psilocybin can influence neurotransmitters like serotonin, potentially affecting mental health conditions such as depression and anxiety. Microdosing with small amounts has been explored for its effects on creativity and cognitive function without causing hallucinations or altered states of consciousness. However, research also highlights the need for caution due to potential risks including psychological distress in some individuals.

Connections to other topics might include serotonin pathways, mental health treatments, and psychedelic therapy trends. Evidence quality varies, with more robust studies needed to fully understand long-term effects and therapeutic applications.

Sources

• Psilocybin and hallucinogenic mushrooms. (PMID:39789676)
• Psilocybin mushrooms (“Magic Mushrooms”). (PMID:35952083)
• Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity. (PMID:39897712)
• Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. (PMID:35918311)
• The Therapeutic Potential of Psilocybin. (PMID:34063505)
• [[Hallucinogenic mushrooms].](https://pubmed.ncbi.nlm.nih.gov/16401965/) (PMID:16401965)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._